diminished ovarian reserve
Conditions
Interventions
VD group:VD combined with estrogen-progestin sequential therapy
control group:estrogen-progestin sequential therapy
Erwu Hefang group:Erwu Hefang combined with estrogen-progestogen sequential treatment
Sponsors
Provincial Hospital of Shandong First Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: a. 18 years old = age < 40 years old; b. Meet the criteria of Western medicine diagnosis and Chinese medicine identification; c.Not taking estrogen-progestogen drugs in the last three months; d. Good compliance and voluntary cooperation to complete the treatment.
Exclusion criteria
Exclusion criteria: a. Poor compliance and inability to cooperate in completing the treatment; b.Combined with other endocrine diseases such as hyperprolactinemia and abnormal thyroid function; c.Congenital or acquired malformation of reproductive organs; d.Those who suffer from major cardiovascular and cerebrovascular diseases, mental diseases or malignant tumors; e.Those who take other medication that may affect the evaluation of efficacy; f. Those with abnormal liver or kidney function, abnormal coagulation function and other diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 25-(OH)-D;VDR;CYP2R1; | — |
Secondary
| Measure | Time frame |
|---|---|
| FSH;Basal antral follicle count;Kidney deficiency syndrome scores;LH;E2;AMH; | — |
Countries
China
Contacts
Public ContactPingping Cai
Provincial Hospital of Shandong First Medical University
Outcome results
None listed